SIEMENS MEDICAL SOLUTIONS USA, INC for SIEMENS MEDICAL SOLUTIONS USA, INC
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
American Rescue Plan Act of 2021, HR 1319: Funding for testing, and other covid-19 policies; Covid-19 Testing: Policies associated with use of serology and antigen testing; Verifying Accurate Leading-Edge IVCT Development Act (VALID), S. 2209 (A bill to amend the Federal Food, Drug, and Cosmetic Act to provide for the regulation of in vitro clinical tests, and for other purposes), HR 4128 (A bill to amend the Federal Food, Drug, and Cosmetic Act to provide for the regulation of in vitro clinical tests, and for other purposes); Medical Device User Fee Agreement; Service of medical devices; Right to Repair; Artificial Intelligence for imaging devices; Cybersecurity for legacy imaging equipment
| Lobbyist | Covered position, as disclosed |
|---|---|
| MARK ESHERICK | — |
| ELEANOR WENNER KERR | — |
Medical/Disease Research/Clinical Labs MED
Legislation to appropriately pay for PET diagnostic drugs.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MARK ESHERICK | — |
| ELEANOR WENNER KERR | — |
Trade (domestic/foreign) TRD
Export of raw materials to China.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MARK ESHERICK | — |
| ELEANOR WENNER KERR | — |
Homeland Security HOM
National Interest Exemptions.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MARK ESHERICK | — |
| ELEANOR WENNER KERR | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.